ATOX CO., LTD has long experience at providing radiation management and facility maintenance management for nuclear power plants, nuclear fuel fabrication facilities and other radioisotope handling facilities.
As a new challenge to expand our business upon medical technology, the investigational PET drug manufacturing project has been started at 2011 in cooperation with IBRI (Institute of Biomedical Research and Innovation).
At the same time, we also support facilities to obtain the certificate of “PET drug manufacturing site qualification” from JSNM (Japanese Society of Nuclear Medicine).